Filament Health (Filament) and Jaguar Health (Jaguar) joined forces in early 2023 to create Magdalena Biosciences, Inc. in order to leverage their mutual expertise in botanical drug development, plant sourcing and sustainable supply, scientific advisors including Jaguar’s Scientific Strategy Team (expert ethnobotanists, physicians, and ethnopharmacologists), neuroscience capabilities, regulatory experience with FDA for botanical drug approval, benefit sharing with indigenous populations, expertise in clinical development, manufacturing, bioassay preparation and performance, and Jaguar's knowledge-based library of plants and extracts developed with help from SST. In addition, animal disease model familiarity, including FDG PET scan for assessment of activity, and other models of neuropsychiatric diseases. OneSmallPlanet (OSP), who made the seed investment in Magdalena, invests in programs where there is benefit sharing with indigenous populations, including drug development programs.